Analysis and variability of TGFβ measurements in cancer patients with skeletal metastases

Por O’Brien, Peter J, Ramanathan, Rajeev, Yingling, Jonathan M, Baselga, Jose, Rothenberg, Mace L, Carducci, Michael, Daly, Thomas, Adcock, Dorothy, Lahn, Michael
Publicado em 2008

INSULIN-LIKE GROWTH FACTOR-1 RECEPTOR INHIBITOR, AMG-479, IN CETUXIMAB-REFRACTORY HEAD AND NECK SQUAMOUS CELL CARCINOMA

Por Chung, Christine H., Pohlmann, Paula R., Rothenberg, Mace L., Burkey, Brian B., Parker, Joel, Palka, Kevin, Aulino, Joseph, Puzanov, Igor, Murphy, Barbara
Publicado em 2010

Dual blockade of the EGFR and COX-2 pathways: A phase II trial of cetuximab and celecoxib in patients with chemotherapy refractory metastatic colorectal cancer

Por Chan, Emily, LaFleur, Bonnie, Rothenberg, Mace L., Merchant, Nipun, Lockhart, A. Craig, Trivedi, Bakula, Chung, Christine H., Coffey, Robert J., Berlin, Jordan D.
Publicado em 2011

Analysis of neurosensory adverse events induced by FOLFOX4 treatment in colorectal cancer patients: a comparison between two Asian studies and four Western studies

Por Sugihara, Kenichi, Ohtsu, Atsushi, Shimada, Yasuhiro, Mizunuma, Nobuyuki, Gomi, Katsushige, Lee, Po-Huang, Gramont, Aimery, Rothenberg, Mace L, André, Thierry, Brienza, Silvano, Goldberg, Richard M
Publicado em 2012

A Phase I and Pharmacokinetic Study of the Oral Histone Deacetylase Inhibitor, MS-275, in Patients with Refractory Solid Tumors and Lymphomas

Por Gore, Lia, Rothenberg, Mace L., O'Bryant, Cindy L., Schultz, Mary Kay, Sandler, Alan B., Coffin, Denise, McCoy, Candice, Schott, Astrid, Scholz, Catherine, Eckhardt, S. Gail
Publicado em 2008

A phase I study of subcutaneously administered aflibercept (VEGF trap) in a new formulation in patients with advanced solid tumors

Por Wang-Gillam, Andrea, Tew, William P., Rothenberg, Mace L., Dupont, Jakob, Cooper, Wendy, Sternas, Lars, Buzenet, Giliane, Sosman, Jeffrey A., Spriggs, David R., Lockhart, Albert Craig
Publicado em 2011

Safety Analysis of FOLFOX4 Treatment in Colorectal Cancer Patients: A Comparison Between Two Asian Studies and Four Western Studies

Por Sugihara, Kenichi, Ohtsu, Atsushi, Shimada, Yasuhiro, Mizunuma, Nobuyuki, Lee, Po-Huang, de Gramont, Aimery, Goldberg, Richard M., Rothenberg, Mace L., André, Thierry, Brienza, Silvano, Gomi, Katsushige
Publicado em 2011

Phase III, Randomized Study of Gemcitabine and Oxaliplatin Versus Gemcitabine (fixed-dose rate infusion) Compared With Gemcitabine (30-minute infusion) in Patients With Pancreatic...

Por Poplin, Elizabeth, Feng, Yang, Berlin, Jordan, Rothenberg, Mace L., Hochster, Howard, Mitchell, Edith, Alberts, Steven, O'Dwyer, Peter, Haller, Daniel, Catalano, Paul, Cella, David, Benson, Al Bowen
Publicado em 2009

Phase I, Pharmacokinetic and Pharmacodynamic Study of SJG-136, a Novel DNA Sequence Selective Minor Groove Cross-Linking Agent, in advanced solid tumors

Por Puzanov, Igor, Lee, Wooin, Chen, Alice P., Calcutt, M. Wade, Hachey, David. L., Vermeulen, Wendy L., Spanswick, Victoria J., Liao, Chih-Yi, Hartley, John A., Berlin, Jordan D., Rothenberg, Mace L.
Publicado em 2011

TACE/ADAM-17: A Component of the Epidermal Growth Factor Receptor Axis and a Promising Therapeutic Target in Colorectal Cancer

Por Merchant, Nipun B., Voskresensky, Igor, Rogers, Christopher M., LaFleur, Bonnie, Dempsey, Peter J., Graves-Deal, Ramona, Revetta, Frank, Foutch, A. Coe, Rothenberg, Mace L., Washington, Mary K., Coffey, Robert J.
Publicado em 2008

Factors affecting the pharmacokinetics and pharmacodynamics of PEGylated liposomal irinotecan (IHL-305) in patients with advanced solid tumors

Por Wu, Huali, Infante, Jeffrey R, Keedy, Vicki L, Jones, Suzanne F, Chan, Emily, Bendell, Johanna C, Lee, Wooin, Kirschbrown, Whitney P, Zamboni, Beth A, Ikeda, Satoshi, Kodaira, Hiroshi, Rothenberg, Mace L, Burris, Howard A, Zamboni, William C
Publicado no Int J Nanomedicine (2015)

Phase I Study of Intravenous Vascular Endothelial Growth Factor Trap, Aflibercept, in Patients With Advanced Solid Tumors

Por Lockhart, A. Craig, Rothenberg, Mace L., Dupont, Jakob, Cooper, Wendy, Chevalier, Paul, Sternas, Lars, Buzenet, Giliane, Koehler, Elizabeth, Sosman, Jeffrey A., Schwartz, Lawrence H., Gultekin, David H., Koutcher, Jason A., Donnelly, Edwin F., Andal, Ric, Dancy, Isabelle, Spriggs, David R., Tew, William P.
Publicado em 2010

Molecular Imaging of Therapeutic Response to Epidermal Growth Factor Receptor Blockade in Colorectal Cancer

Por Manning, H. Charles, Merchant, Nipun B., Foutch, A. Coe, Virostko, John M., Wyatt, Shelby K., Shah, Chirayu, McKinley, Eliot T., Xie, Jingping, Mutic, Nathan J., Washington, M. Kay, LaFleur, Bonnie, Tantawy, Mohammed Noor, Peterson, Todd E., Ansari, M. Sib, Baldwin, Ronald M., Rothenberg, Mace L., Bornhop, Darryl J., Gore, John C., Coffey, Robert J.
Publicado em 2008

A simplified interventional mapping system (SIMS) for the selection of combinations of targeted treatments in non-small cell lung cancer

Por Lazar, Vladimir, Rubin, Eitan, Depil, Stephane, Pawitan, Yudi, Martini, Jean-François, Gomez-Navarro, Jesus, Yver, Antoine, Kan, Zhengyin, Dry, Jonathan R., Kehren, Jeanne, Validire, Pierre, Rodon, Jordi, Vielh, Philippe, Ducreux, Michel, Galbraith, Susan, Lehnert, Manfred, Onn, Amir, Berger, Raanan, Pierotti, Marco A., Porgador, Angel, Pramesh, CS, Ye, Ding-wei, Carvalho, Andre L., Batist, Gerald, Le Chevalier, Thierry, Morice, Philippe, Besse, Benjamin, Vassal, Gilles, Mortlock, Andrew, Hansson, Johan, Berindan-Neagoe, Ioana, Dann, Robert, Haspel, Joel, Irimie, Alexandru, Laderman, Steve, Nechushtan, Hovav, Al Omari, Amal S., Haywood, Trent, Bresson, Catherine, Soo, Khee Chee, Osman, Iman, Mata, Hilario, Lee, Jack J., Jhaveri, Komal, Meurice, Guillaume, Palmer, Gary, Lacroix, Ludovic, Koscielny, Serge, Eterovic, Karina Agda, Blay, Jean-Yves, Buller, Richard, Eggermont, Alexander, Schilsky, Richard L., Mendelsohn, John, Soria, Jean-Charles, Rothenberg, Mace, Scoazec, Jean-Yves, Ki Hong, Waun, Kurzrock, Razelle
Publicado no Oncotarget (2015)